-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

703.P1.53 703. Cellular Immunotherapies: Basic and Translational: Poster I

Symposia: Cellular Immunotherapies: Basic and Translational Program: Oral and Poster Abstracts
Type: Poster
Saturday, December 9, 2023: 5:30 PM-7:30 PM
Halls G-H (San Diego Convention Center)

Andreas Linder, MD1,2*, Daniel Nixdorf, MSc3,4*, Niklas Kuhl2*, Ignazio Piseddu, MD2,4*, TengTeng Xu, MSc3*, Gunnar Kuut, Dr.2*, Simon Veth, Dr.5*, Thomas Carell, Prof. Dr.5*, Roman Kischel, MD6*, Veit Hornung, Prof. Dr.2* and Marion Subklewe, MD3,4,7

1Department of Medicine II, LMU University Hospital, LMU Munich, Munich, DEU
2Gene Center and Department of Biochemistry, LMU Munich, Munich, Germany
3Laboratory for Translational Cancer Immunology, Gene Center, LMU Munich, Munich, Germany
4Department of Medicine III, LMU University Hospital, LMU Munich, Munich, Germany
5Department of Chemistry, LMU Munich, Munich, Germany
6Amgen Research (Munich) Gmbh, Munich, Germany
7German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Heidelberg, Germany

Manpreet Bariana1*, Mark Batistick1*, Mathias Oelke2*, Sojung Kim2*, Elena Cassella1*, Sidharth Anand1*, Shaina Anuncio1*, Ashley Varkey1,3, Ruipeng Wang2*, Jack Ragheb2*, David Siegel4* and Johannes Zakrzewski1,3,5

1Center for Discovery and Innovation, Hackensack Meridian Health, Nutley, NJ
2NexImmune Inc., Gaithersburg, MD
3Department of Pediatrics, Hackensack University Medical Center, Hackensack
4Hackensack University Medical Center, Hackensack, NJ
5Department of Oncology, Georgetown University, Washington DC

Yuki Takeuchi, MD1*, Seitaro Terakura, MD, PhD1, Shiho Hirano, MD1*, Hirofumi Yokota, MD1*, Shihomi Kuwano, MD1*, Masahide Osaki, MD1*, Yoshitaka Adachi, MD, PhD1*, Kanae Imai, MD1*, Jakrawadee Julamanee, MD, PhD2, Ryo Hanajiri, MD, PhD1*, Makoto Murata, M.D., Ph.D.1 and Hitoshi Kiyoi, MD, PhD1

1Nagoya University Graduate School of Medicine, Nagoya, Japan
2Prince of Songkla University, Songkhla, Thailand

Giulia Petra Rappa, BSc1,2*, Monika Sponheimer1,2*, Gerulf Hänel, Ph.D.1,2*, Anne-Sophie Neumann, M.Sc.1,2*, Nora Philipp1,2*, Koorosh Korfi, PhD3, Sylvia Herter, PhD3*, Johannes Sam, PhD3*, Franz Schuler4*, Christian Klein, PhD3, Marina Bacac, PhD3*, Pablo Umana, PhD3 and Marion Subklewe, MD1,2,5

1Department of Medicine III, LMU University Hospital, LMU Munich, Munich, Germany
2Laboratory for Translational Cancer Immunology, Gene Center, LMU Munich, Munich, Germany
3Roche Pharma Research & Early Development, Roche Innovation Center Zurich, Schlieren, Switzerland
4Roche Pharma Research & Early Development, Roche Innovation Center Basel, Basel, Switzerland
5German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Heidelberg, Germany

Johannes Spehr, Ph.D.1*, Jan-Erik Meyer, Ph.D.1*, Simon Loff, Ph.D.1*, Anika Langer, Ph.D.1*, Moritz Langer, M.Sc.1*, Ben Boyerinas, Ph.D.2*, Isabelle Le Mercier, Ph.D.2*, Reynald Lescarbeau, Ph.D.2*, Marc Cartellieri, Ph.D.1* and Armin Ehninger3*

1AvenCell Europe GmbH, Dresden, Germany
2AvenCell Therapeutics, Inc., Watertown, MA
3AvenCell Europe GmbH, Dresden, Sachsen, Germany

Spencer Goodman1*, Kenyon Lyon1*, Katelin Hartwig1*, Suping Peng1*, Qin Li1*, David Murray1*, Davide Bernareggi1*, Caryn Gonsalves1*, Max Schabla1*, Guoxin Zhang1*, Terri Harder1*, Baohu Ji1*, Leah Mitchell1*, Dan S Kaufman, MD, PhD2, Robert Hollingsworth1* and Huang Zhu1*

1Shoreline Biosciences, San Diego, CA
2University of California San Diego, La Jolla, CA

Jianghua Wu1*, Wenjing Luo1*, Lu Tang2*, Zhaozhao Chen3*, Jie Zhou2*, Chenggong Li4*, Wei Xiong5*, Heng Mei6* and Yu Hu, MD6*

1Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong Univer, Wuhan, CHN
2Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China, Wuhan, CHN
3Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China, Wuhan, China
4Union Hospital, Tongji Medical College, Huazhong University of Science and Techn, Wuhan, CHN
5Wuhan Sian Medical Technology Co., Ltd, Wuhan, China
6Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China

Heng Mei1,2*, Zhaozhao Chen, Doctor3,4*, Yu Hu, MD2,5,6* and Heng Mei6,7*

1Department of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
2Hubei Clinical and Research Centre of Thrombosis and Haemostasis, Wuhan, China
3Hubei Clinical Medical Center of Cell Therapy for Neoplastic Disease, Wuhan, China
4Institute of Hematology, Union Hospital,, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
5Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
6Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
7Union hospital of Huazhong University of Science and Technology, Wuhan, CHN

Yaya Chu, PhD1*, Keira Foley1*, Meijuan Tian, PhD1*, Kayleigh Klose, MD2*, Jessica Ayala-Cuesta, MD1*, Dean Anthony Lee, MD, PhD3, Mario Marcondes, MD/PhD4*, Christian Klein, PhD5 and Mitchell S. Cairo, MD1,6,7,8,9

1Department of Pediatrics, New York Medical College, Valhalla, NY
2Department of Pediatrics, New York Medical College, White Plains, NY
3Center for Childhood Cancer, Abigail Wexner Research Institute, Nationwide Children’s Hospital, Columbus, OH
4Nektar Therapeutics, San Francisco, CA
5Roche Innovation Center Zurich, Roche/Genentech, Schlieren, Switzerland
6Department of Medicine, New York Medical College, Valhalla, NY
7Department of Cell Biology and Anatomy, New York Medical College, Valhalla, NY
8Department of Epidemiology and Community Health, New York Medical College, Valhalla, NY
9Department of Pathology/Microbiology and Immunology, New York Medical College, Valhalla, NY

Haley M. Simpson, MD, PhD1, Brett M Stevens, PhD, BS1*, Craig T. Jordan, PhD2 and M. Eric Kohler, MD, PhD3

1University of Colorado, Aurora, CO
2University of Colorado School of Medicine, Aurora, CO
3Department of Pediatrics- Hematology, Oncology, and Bone Marrow Transplant, University of Colorado School of Medicine, Aurora, CO

Tien-Ching Chang1*, Amanda Heard2*, John Warrington1*, Jack Landmann3*, Sadia Afrin4*, Jufang Chang4*, Mehmet Emrah Selli, PhD4*, Yu-Sung Hsu1* and Nathan Singh, MD5

1Washington University, St Louis, MO
2Washington University, St Louis
3Washington University School of Medicine, St. Louis, MO
4Washington University School of Medicine, Saint Louis, MO
5Washington University, St. Louis, Saint Louis, MO

Kathrine S Rallis, MBBS, MSc1, Jessica Liegel, MD2, Giulia Cheloni, PhD2*, Poorva Bindal, MD2, Isabella Saldarriaga3*, Junyan Zhang2*, Georges Chedid, MD3*, Joseph Abirached, BS2*, John G. Clohessy, PhD2*, Sophia Adamia, PhD3, Kai W Wucherpfennig, MD, PhD4*, Donald Kufe, MD5*, Jacalyn Rosenblatt, MD2 and David Avigan, MD2

1Beth Israel Deaconess Medical Center, Brookline, MA
2Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA
3Beth Israel Deaconess Medical Center, Boston, MA
4Dana Farber Cancer Institute, Harvard Medical School, Boston, MA
5Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA

Jennifer Tran, BS1*, Jennifer Ann Foltz, PhD1*, Pamela Wong, BS1*, Changxu Fan, BS1*, Michelle Becker-Hapak, BS1*, Nancy D Marin, PhD1*, Celia C Cubitt, BS1*, David A Russler-Germain, MD, PhD, BS1, Mark Foster, BS, MS1*, Timothy Schappe, BS1*, Lynne Marsala, BS1*, Joseph Rueve, BS1*, Kimberly Hwang1*, Ting Wang, PhD1*, Melissa M Berrien-Elliott, PhD1*, Amanda F Cashen1, Jeffrey J. Bednarski, MD, PhD1, Obi Griffith, PhD1*, Malachi Griffith, PhD1*, Allegra Petti, PhD2* and Todd A Fehniger, MD, PhD3

1Washington University School of Medicine in St. Louis, St Louis, MO
2Massachusetts General Hospital, Boston, MA
3Washington University School of Medicine in St. Louis, Saint Louis, MO

Adila Izgutdina, MD1*, William C Temple, MD2,3, Matthew Andrew Nix, PhD1*, Huimin Geng, PhD1*, Emilio Ramos, MD, PhD1, Akul Naik, BS1*, Rebecca Larson, PhD4,5*, Fernando Salangsang6*, Paul Phojanakong, BA6*, Juan Antonio Camara Serrano, PhD6*, Ons Zakraoui, PhD7*, Isa Tariq, BS7*, Marcela V Maus, MD, PhD4,5,8, Veronica Steri, PhD6* and Arun P Wiita, MD, PhD1

1Department of Laboratory Medicine, University of California, San Francisco, San Francisco, CA
2Department of Pediatrics, Division of Hematology/Oncology, UCSF Benioff Children's Hospital, University of California, San Francisco, San Francisco, CA
3Department of Pediatrics, Division of Allergy, Immunology, and Bone Marrow Transplantation, UCSF Benioff Children's Hospital, University of California, San Francisco, San Francisco, CA
4Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, MA
5Harvard Medical School, Boston, MA
6Preclinical Therapeutics Core, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA
7Preclinical Therapeutics Core, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA
8Blood and Marrow Transplant Program, Massachusetts General Hospital, Boston, MA

Juan Roberto Rodriguez-Madoz, PhD1,2*, Lorea Jordana-Urriza1*, Guillermo Serrano, PhD3*, Aina Oliver Caldes, MD4*, Maria Erendira Calleja-Cervantes, PhD1,3*, Patxi San-Martin1*, Amaia Vilas-Zornoza1,2*, Asier Ullate-Agote1*, Aintzane Zabaleta1,2,5*, Diego Alignani1,2,5*, Teresa Lozano, PhD6*, Valentin Cabanas Perianes, MD7*, Juan Luis Reguera, MD8*, Almudena Navarro-Bailon9*, Marta Español-Rego, MD, PhD10*, Mariona Pascal, PhD10*, Jose Maria Moraleda, MD, PhD7*, Jose A. Perez-Simon, MD, PhD8*, Maria Victoria Mateos, MD, PhD2,9, Fermin Sanchez-Guijo Martin, MD, PhD2,11*, Alvaro Urbano-Ispizua Sr., MD4, Manel Juan, MD, PhD10*, Ana Alfonso Pierola, M.D., Ph.D.12,13,14*, Jose J. Rifon, M.D.2,12,13*, Paula Rodriguez Otero, MD, PhD2,12,13*, Bruno Paiva1,2,12,15*, Susana Inogés, MD, PhD2,13,16*, Ascensión López-Díaz De Cerio2,13,16*, Juan J Lasarte, PhD6,12*, Jesús San Miguel, MD, PhD1,2,12,17*, Carlos Fernández de Larrea4*, Mikel Hernaez, PhD2,3,18* and Felipe Prosper, MD, PhD1,2,12,13

1Hemato-Oncology Program. Cima Universidad de Navarra. IdiSNA., Pamplona, Spain
2Centro de Investigacion Biomedica en Red de Cancer (CIBERONC)., Madrid, Spain
3Computational Biology Program. Cima Universidad de Navarra. IdiSNA., Pamplona, Spain
4Department of Hematology. Hospital Clinic de Barcelona. IDIBAPS. Universidad de Barcelona., Barcelona, Spain
5Flow Cytometry Core. Cima Universidad de Navarra. IdiSNA., Pamplona, Spain
6Immunology and Immunotherapy Program. Cima Universidad de Navarra. IdiSNA., Pamplona, Spain
7Department of Hematology, IMIB-Virgen de la Arrixaca University Hospital. University of Murcia., Murcia, Spain
8Department of Hematology, University Hospital Virgen del Rocio-IBIS. Universidad de Sevilla., Sevilla, Spain
9Hematology Department, IBSAL-University Hospital of Salamanca. University of Salamanca., Salamanca, Spain
10Department of Immunology. Hospital Clinic de Barcelona. IDIBAPS. Universidad de Barcelona., Barcelona, Spain
11Hospital Universitario de Salamanca, Instituto de Investigacion Biomedica de Salamanca (IBSAL), Centro de Investigación del Cancer (IBMCC-USAL, CSIC), Salamanca, Spain
12Cancer Center Universidad de Navarra (CCUN)., Pamplona, Spain
13Hematology and Cell Therapy Department. Clinica Universidad de Navarra, IdiSNA., Pamplona, Spain
14Centro de Investigacion Biomedica en Red de Cancer (CIBERONC), Madrid, Spain
15Flow Cytometry Core, Centre for Applied Medical Research (CIMA), Instituto de Investigaciones Sanitarias de Navarra (IdiSNA), Cancer Center Clinica Universidad de Navarra (CCUN), Pamplona, Spain
16Immunology and Immunotherapy Department. Clinica Universidad de Navarra., Pamplona, Spain
17Cancer Center Clínica Universidad de Navarra (CCUN), CIMA, CIBERONC, IDISNA, Pamplona, Spain
18Data Science and Artificial Intelligence Institute (DATAI). Universidad de Navarra., Pamplona, Spain

Mirko Farina, MD1*, Marco Chiarini, PhD2*, Anna Galvagni2*, Eugenia Accorsi Buttini1*, Vera Radici, MD1*, Emilio Ferrari3*, Andrea Bianchetti3*, Alessandra Beghin4*, Francesco Zuccalà5*, Simone Piva6*, Loris Poli7*, Andrea Pilotto7*, Alessandro Leoni1,8*, Giovanni Campisi1*, Federica Re1,8*, Simona Bernardi, PhD1,8*, Nicola Polverelli, MD1, Enrico Morello, MD1*, Chiara Cattaneo, MD9, Daniele Moratto2*, Alessandro Padovani7*, Arnalda Lanfranchi4*, Camillo Almici, MD3*, Duilio Brugnoni2*, Alessandra Tucci, MD9, Michele Malagola1*, Alessandro Re, MD9* and Domenico Russo, MD, PhD1*

1Unit of Blood Diseases and Bone Marrow Transplantation, Cell Therapies and Hematology Research Program, Department of Clinical and Experimental Science, University of Brescia, ASST Spedali Civili di Brescia, Brescia, Italy
2Clinical Chemistry Laboratory, Flow Cytometry Section, ASST Spedali Civili Di Brescia, Brescia, Italy
3Laboratory for Stem Cells Manipulation and Cryopreservation, Department of Transfusion Medicine, ASST Spedali Civili of Brescia, Brescia, Italy
4Stem Cell Lab, ASST Spedali Civili of Brescia, Brescia, Italy
5First Division of Anesthesiology and Critical Care Medicine, ASST Spedali Civili of Brescia, Brescia, Italy
6University Division of Anesthesiology and Critical Care Medicine, University of Brescia, ASST Spedali Civili of Brescia, Brescia, Italy
7Neurology Unit, University of Brescia, ASST Spedali Civili of Brescia, Brescia, Italy
8Centro di Ricerca Emato-Oncologica AIL (CREA), ASST Spedali Civili, Brescia, Italy
9Hematology, ASST Spedali Civili di Brescia, Brescia, Italy

Yoshiki Furukawa, MD1*, Midori Ishii2*, Ayaka Goto2*, Shintaro Kinoshita2*, Jun Ando2,3*, Hiromitsu Nakauchi4,5* and Miki Ando, MD, phD2

1Department of Hematology, Juntendo University School of Medicine, Hongo, Bunkyo-Ku, Japan
2Department of Hematology, Juntendo University School of Medicine, Tokyo, Japan
3Division of Cell Therapy & Blood Transfusion Medicine, Juntendo University School of Medicine, Tokyo, Japan
4Institute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, Stanford
5Stem Cell Therapy Laboratory, Advanced Research Institute, Tokyo Medical and Dental University, Tokyo, Japan

Weijun Zhou1*, Jinyi Yu2*, Fuyu Li3* and Kankan Wang, MD, PhD4*

1Hematology, Zhujiang Hospital of Southern Medical University, Guangzhou, China
2Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, CHN
3Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China
4Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China

Michael S Magee*, Alberto De Iaco, PhD*, Jason Rodriguez, PhD*, James B. Rottman*, Donghui Liu, PhD*, Giulia Schiroli*, Pooja Sabhachandani, PhD*, Yu Cao*, Rebecca Levy, MS*, Mohit Gupta*, Michael T. Monte*, Jane Wang, PhD*, Bill Querbes, PhD*, Cecilia Cotta-Ramusino, PhD*, Madhusudan V Peshwa, PhD* and Michael C Holmes, PhD*

Tessera Therapeutics, Somerville, MA

Ricky Tirtakusuma, PhD1*, Mohamed A. Ghonim, PhD1*, Stefan Schattgen, PhD1*, Jing Ma, PhD2*, Brad Muller, MD3*, Kasi Vegesana, PhD1*, Emma Allen, PhD1*, Jeffery M. Klco, MD, PhD1 and Paul G. Thomas, PhD4*

1St. Jude Children's Research Hospital, Memphis, TN
2Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN
3St. Jude Children's Research Hospital, Memphis
4Department of Immunology, St. Jude Children’s Research Hospital, Memphis, TN

Anuj Verma1*, Samuel Liburd2*, Zsuzsanna Tobias, PhD3*, Iris Isufi4, Jordan Pober, MD, PhD2* and Mina L Xu, MD2*

1Yale University School of Medicine, New Haven, CT
2Yale University, New Haven, CT
3Yale, New Haven, CT
4Department of Internal Medicine, Yale School of Medicine, Yale University, New Haven, CT

Mengtao Qin, BS1,2*, Erica Braverman, MD3, Herbert Schuler3*, Manda Ramsey3*, Christopher Wittmann3* and Craig Byersdorfer, MD3

1School of Medicine, Tsinghua University, Pittsburgh, PA
2School of Medicine, University of Pittsburgh, Pittsburgh, PA
3UPMC, Department of Pediatrics, Division of Blood and Marrow Transplantation and Cellular Therapies, UPMC Children’s Hospital of Pittsburgh, Pittsburgh, PA

Miriam Y Kim, MD1, Matthew L. Cooper, PhD2, Julie K. Ritchey1*, Julie O'Neal, PhD1* and John DiPersio3

1Department of Medicine, Division of Oncology, Washington University School of Medicine, Saint Louis, MO
2Wugen Inc., Saint Louis, MO
3Washington University School of Medicine, Saint Louis, MO

David M. Cordas dos Santos, MD1,2,3*, Amar Hadzic, MSc1,2*, Martin E. Kirmaier, MSc1,2*, Werner Schmitz, PhD4*, Viktoria Blumenberg, MD1,3,5, Kai Rejeski, MD1,3,5, Veit L. Buecklein, MD1,5*, Michael von Bergwelt-Baildon, MD, PhD1,3*, Marion Subklewe, MD1,3,5 and Sebastian Theurich, MD1,2,3*

1Department of Medicine III, LMU University Hospital, Munich, Germany
2Cancer- and Immunometabolism Research Group, LMU Gene Center, Munich, Germany
3German Cancer Consortium (DKTK), Partner Site Munich, Munich, Germany
4Department of Biochemistry and Molecular Biology, Theodor Boveri Institute, Biocenter, University of Wuerzburg, Wuerzburg, Germany
5Laboratory for Translational Cancer Immunology, LMU Gene Center, Munich, Germany

Shintaro Kinoshita1*, Midori Ishii1*, Yoshiki Furukawa, MD2*, Shoko Sato1*, Jun Ando1,3*, Hiromitsu Nakauchi4,5* and Miki Ando, MD, phD1

1Department of Hematology, Juntendo University School of Medicine, Tokyo, Japan
2Department of Hematology, Juntendo University School of Medicine, Hongo, Bunkyo-Ku, Japan
3Division of Cell Therapy & Blood Transfusion Medicine, Juntendo University School of Medicine, Tokyo, Japan
4Institute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, Stanford
5Stem Cell Therapy Laboratory, Advanced Research Institute, Tokyo Medical and Dental University, Tokyo, Japan

Tianning Gu1*, Meng Zhu2*, Yingli Han3*, Rui Wang4*, Pengxu Qian, PhD5* and He Huang6*

1Bone Marrow Transplantation Center, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
2Zhejiang University, Hangzhou, CHN
3The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, CHN
4Zhejiang University, Hangzhou, China
5Institute of Hematology, Zhejiang University, Hangzhou, China
6Bone Marrow Transplantation Center, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China

Manali Begur, MS1, Takayoshi Yamauchi, PhD2*, Hidehito Saito, PhD3*, Takaaki Oba, PhD4*, Ryutaro Kajihara, PhD4*, Leighton Stein, BS5*, Mark Hoenerhoff, DVM, PhD6* and Fumito Ito, MD, PhD1,7*

1Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA
2Norris Comprehensive Cancer Center, University of Southern California, Los Angeles
3Department of Surgery, University of Michigan, Ann Arbor, MI
4Center for Immunotherapy, Roswell Park Comprehensive Cancer Center, Buffalo, NY
5Center of Immunotherapy, Roswell Park Comprehensive Cancer Center, Buffalo, NY
6University of Michigan, Ann Arbor, MI
7University of Southern California, Los Angeles, CA

Kole R. Degolier1,2*, Etienne Danis, PhD3*, Jennifer Cimons, BSc1,2*, Michael Yarnell, BSc4*, Ross Kedl, PhD5*, M. Eric Kohler, MD, PhD4, James Scott-Browne, PhD6* and Terry J. Fry, MD4,7

1Department of Pediatrics- Hematology, Oncology, and Bone Marrow Transplant, University of Colorado School of Medicine, Denver, CO
2Immunology Graduate Program, University of Colorado School of Medicine, Aurora, CO
3Biostatistics and Bioinformatics Shared Resource, University of Colorado Anschutz Medical Campus, Aurora, CO
4Department of Pediatrics- Hematology, Oncology, and Bone Marrow Transplant, University of Colorado School of Medicine, Aurora, CO
5Department of Immunology and Microbiology, University of Colorado School of Medicine, Aurora
6Department of Immunology and Genomic Medicine, National Jewish Health, Denver, CO
7Sana Biotechnology, Seattle, WA

Pinar Ataca Atilla, MD1*, Sylvain Simon, PhD1*, Erden Atilla, MD1*, Melissa L Comstock1*, Andrew J. Cowan, MD2,3,4, Geoffrey R Hill, MD1,2, Stanley R. Riddell, MD1,5 and Damian J Green, MD1,5

1Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA
2Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, WA
3Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA
4Division of Medical Oncology, Fred Hutchinson Cancer Research Center, Seattle, WA
5University of Washington, Seattle, WA

Won Lee, PhD1*, Destanie Rose, PhD1*, Heather Gustafson2,3, Meredith Jackson, PhD4*, Kamila Gwiazda, PhD5*, Joshua Gustafson, PhD6*, Mariliis Ott7*, Rebecca Gardner, MD8, James G Keck9* and Jiwon Yang, PhD1*

1Innovation & Product Development, The Jackson Laboratory, Sacramento, CA
2Department of Pediatrics, University of Washington School of Medicine, Seattle, WA
3Ben Towne Center for Childhood Cancer Research, Seattle, WA
4Artisan Bio, Louisville, CO
5Seattle Children’s Therapeutics, Seattle Children’s Hospital, Seattle, WA
6Seattle Children’s Therapeutics, Seattle Children's Hospital, Seattle, WA
7Sana Biotechnology, Seattle, WA
8Division of Hematology-Oncology, Seattle Children's Hospital, Seattle, WA
9The Jackson Laboratory, Sacramento, CA

Kazusa Ishii, MD, MPH1, Zhihui Liu, Ph.D.1*, John S Davies, Ph.D.1,2*, Kilyna A Nguyen1*, Crystal P McIntosh1*, Tejas Kadakia, Ph.D.1,3*, Scott M Norberg, D.O.1*, Zachary Rae1,4*, Sooraj Achar, B.S.1*, Gregoire Altan-Bonnet, Ph.D.1*, Xiaolin Wu, Ph.D.5*, Michael C Kelly, Ph.D.1*, Naomi Taylor, M.D., Ph.D.1 and Christian S Hinrichs, M.D.1,6*

1National Cancer Institute, Bethesda, MD
2Genentech, South San Francisco
3Precigen, Germantown, MD
410x Genomics, Peasanton, CA
5Genomics Technology Laboratory, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, MD
6Duncan and Nancy MacMillan Center of Excellence in Cancer Immunotherapy and Metabolism, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ

Parmeshwar N Amatya, PhD, MPH1, Jingyu Xiang, MD, MSc2*, Julie O'Neal, PhD3*, Julie K. Ritchey3*, Alun J Carter, PhD4*, Matthew L. Cooper, PhD5 and John DiPersio6

1Washington University School of Medicine, Saint Louis, IL
2Washington University School of Medicine, Saint Louis, MO
3Department of Medicine, Division of Oncology, Washington University School of Medicine, Saint Louis, MO
4WUGEN, Saint Louis, MO
5Wugen Inc., Saint Louis, MO
6Division of Oncology, Washington University School of Medicine, Saint Louis, MO

Francesca Alvarez Calderon1,2,3, Ryan A Fleming2*, Lev Gorfinkel1,2,3, Katherine Michaelis, MD, PhD1,2*, Xianliang Rui, PhD2*, James Kaminski, PhD2,4*, Dana Bonin2*, Anick Mallette2*, Katherine Brodeur2*, Heber Domingues2*, Jennifer Lane2*, Victor Tkachev, PhD1,5*, Leslie Kean1,2,3 and Ulrike Gerdemann, MD1,2,3

1Harvard Medical School, Boston, MA
2Division of Hematology-Oncology, Boston Children's Hospital, Boston, MA
3Dana-Farber Cancer Institute, Boston, MA
4Broad Institute of MIT and Harvard, Cambridge, MA
5Center for Transplantation Sciences, Massachusetts General Hospital, Boston, MA

Bijender Kumar1*, Anand Singh, PhD1*, Rafet Basar, MD2*, Nadima Uprety2*, Ye Li, MD, PhD2, Huihui Fan, PhD3*, Mayra Shanley, PhD2*, Sunil Acharya, PhD4*, Mayela Carolina Mendt, PhD2*, Paul Lin, MD, PhD2, Alexander Biederstädt, MD2*, Hind Rafei, MD5, Pinaki Banerjee, PhD2*, Vakul Mohanty, PhD6*, Hila Shaim, MD2, Merve Dede7*, Luciana Melo Garcia, MD, MSc8, Lucila Nassif Kerbauy, MD, PhD2, Ana K. Nunez Cortes, MD2*, Qi Miao7*, Jinzhuang Dou7*, Francia Silva Reyes1*, Xingliang Guo7*, Mecit Kaplan2, Sonny Ang2*, Xin Ru Jiang2*, Enli Liu, MD2*, Bin Liu, PhD2*, Richard E. Champlin, MD2, Hagop Kantarjian, MD9, David Marin, MD2, Ken Chen, PhD6*, Hussein A Abbas, MD, PhD9, Elizabeth J. Shpall, MD2, Kunal Rai, PhD1*, Katy Rezvani, MD10 and May Daher, MD2

1The University of Texas MD Anderson Cancer Center, Houston
2Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
3The University of Texas Health Science Center at Houston, Houston
4D, The University of Texas MD Anderson Cancer Center, Houston, TX
5Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Missouri City, TX
6Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX
7The University of Texas MD Anderson Cancer Center, Houston, TX
8CHU de Québec - Université Laval, Quebec, QC, Canada
9Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
10Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas M D Anderson Cancer Center, Houston, TX

Rafet Basar, MD1*, May Daher, MD2, Nadima Uprety1*, Emily Ensley1*, Ana K. Nunez Cortes, MD1*, Sunil Acharya3*, Rejeena Shrestha4*, Bin Liu, PhD1*, Mayra Shanley, PhD1*, Ye Li, MD, PhD1,5, Francia Silva Reyes6*, Merve Dede7*, Hind Rafei, MD1,8, Hila Shaim, MD7*, Mecit Kaplan1, Paul Lin, MD, PhD1, Pinaki Banerjee, PhD1*, Vakul Mohanty, PhD9*, Jinhuang Dou10*, Mayela Carolina Mendt, PhD1*, Qi Miao9*, Mariam Ammari4*, Enli Liu, MD1*, Xingliang Guo7*, Bijender Kumar6*, Alexander Biederstädt, MD1*, Xin Ru Jiang1*, Sonny Ang1*, Navin Varadarajan, PhD11*, Richard E. Champlin, MD1,12, Ken Chen, PhD9*, David Marin, MD1, Elizabeth J. Shpall, MD1 and Katy Rezvani, MD12

1Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
2Stem Cell Transplantation and Cellular Therapy, MD Anderson Cancer Center, Houston, TX
3UT MD Anderson Cancer Center, Houston
4UT MD Anderson Cancer Center, Houston, TX
5MD Anderson, Houston, TX
6The University of Texas MD Anderson Cancer Center, Houston
7The University of Texas MD Anderson Cancer Center, Houston, TX
8Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Missouri City, TX
9Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX
10UT MD ANderson Cancer Center, Houston, TX
11Department of Chemical and Biomolecular Engineering, University of Houston, Houston, TX
12MD Anderson Cancer Center, Houston, TX

*signifies non-member of ASH